Aurolife Pharma, LLC recalls Fexofenadine Hydrochloride Tablets USP, 180 mg, packaged in a) 30-count carton (NDC 70677-0008-2) and b) 15-count carton
Recalled September 25, 2019 · FDA recall D-1868-2019 · Aurolife Pharma
Hazard
Failed Impurities/Degradation Specifications · FDA Class II
Units
a) 11,928 cartons; b) 288 cartons
Sold at
Nationwide in the USA
Description
Failed Impurities/Degradation Specifications
Product
Fexofenadine Hydrochloride Tablets USP, 180 mg, packaged in a) 30-count carton (NDC 70677-0008-2) and b) 15-count carton (NDC 70677-0008-1), sunmark, Distributed by McKesson, One Post Street, San Francisco, CA 94104.
Manufacturer(s)
Aurolife Pharma, LLC
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →